Suchergebnisse - "van den Eertwegh, Alfonsus J M"

PubPharm (55)

1

A prediction model for response to immune checkpoint inhibition in advanced melanoma

enthalten in: International journal of cancer | 2024

von van Duin, I. | Verheijden, R. | van Diest, P. | +22

2

Prognostic and predictive value of non-steroidal anti-inflammatory drugs in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Kennedy, O. | Glassee, N. | Kicinski, M. | +29

3

Impact of Prior Cytoreductive Nephrectomy on Efficacy in Patients with Synchronous Metastatic Renal Cell Carcinoma Treated with Avelumab plus Axitinib or Sunitinib : Post Hoc Analysis from the JAVELIN Renal 101 Phase 3 Trial

enthalten in: European urology | 2024

von Grimm, M. | Oya, M. | Choueiri, T. | +11

4

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Kennedy, O. | Kicinski, M. | Valpione, S. | +27

5

Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma

enthalten in: International journal of cancer | 2023

von van Duin, I. | Elias, S. | van den Eertwegh, A. | +22

6

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors

enthalten in: Cancers | 2023

von van Not, O. | Wind, T. | Ismail, R. | +21

7

Incidence and survival of castration-resistant prostate cancer patients with visceral metastases : results from the Dutch CAPRI-registry

enthalten in: Prostate cancer and prostatic diseases | 2023

von van den Bergh, G. | Kuppen, M. | Westgeest, H. | +10

8

Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study

enthalten in: British journal of cancer | 2023

von van der Kooij, M. | Joosse, A. | Suijkerbuijk, K. | +16

9

Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma : A Propensity-Matched Outcome Analysis

enthalten in: Cancers | 2023

von De Meza, M. | Blokx, W. | Bonenkamp, J. | +17

10

Association of Immune-Related Adverse Event Management With Survival in Patients With Advanced Melanoma

enthalten in: JAMA oncology | 2022

von van Not, O. | Verheijden, R. | van den Eertwegh, A. | +19

CommentIn: JAMA Oncol. 2023 May 1;9(5):723-724. - PMID 36892846

1
2
3
4
5
6
Nächster »
[6]